SEC CIK 1228603
ROBBINS LARRY
Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| FLEXview stock → | 54,858,459 | 2016-02-02 |
| BKDview stock → | 17,633,572 | 2019-09-25 |
| CYHview stock → | 11,993,795 | 2015-10-22 |
| THCview stock → | 10,645,320 | 2021-04-22 |
| CVSview stock → | 4,824,799 | 2026-05-21 |
| TTWOview stock → | 3,123 | 2006-12-21 |
Position History — CVS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CVS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-05-21 | Open-market sale (derivative) | 378,000 | $93.31 | 0 |
| 2026-05-21 | Open-market sale | 370,462 | $93.45 | 4,824,799 |
| 2026-05-20 | Open-market sale | 800 | $96.28 | 5,195,261 |
| 2026-05-20 | Open-market sale | 66,881 | $95.67 | 5,196,061 |
| 2026-05-20 | Open-market sale | 152,691 | $94.81 | 5,262,942 |
| 2026-05-20 | Open-market sale | 797,628 | $93.48 | 5,415,633 |
| 2026-05-19 | Open-market sale | 151 | $95.18 | 6,213,261 |
| 2026-05-19 | Open-market sale | 1,983,387 | $94.45 | 6,213,412 |
| 2026-05-14 | Grant / award (derivative) | 1,930.005 | $97.15 | 10,147.642 |
| 2025-11-20 | Grant / award (derivative) | 2,202.788 | $76.04 | 8,080.292 |
| 2025-05-15 | Grant / award (derivative) | 2,769.97 | $60.47 | 5,766.71 |
| 2025-05-06 | Open-market sale | 150,000 | $66.67 | 8,196,799 |
| 2025-05-05 | Open-market sale | 1,226,933 | $67.37 | 8,443,798 |
| 2025-05-05 | Open-market sale | 96,999 | $67.99 | 8,346,799 |
| 2025-05-02 | Open-market sale | 373,776 | $69.66 | 9,670,731 |
| 2025-05-02 | Open-market sale | 1,679,736 | $67.39 | 10,267,063 |
| 2025-05-02 | Open-market sale | 222,556 | $68.38 | 10,044,507 |
| 2024-11-21 | Grant / award (derivative) | 2,933.45 | $57.10 | 2,933.45 |
| 2024-11-17 | — | — | — | 11,946,799 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.